Danaher (DHR) Long-Term Deferred Tax (2009 - 2010)
Danaher (DHR) posted Long-Term Deferred Tax of $175.0 million for Q4 2010, down 10.26% on a QoQ basis from $195.0 million in Q4 2009, and down 10.26% year-over-year from $195.0 million in Q4 2009.
Powered by 
Analysis
Danaher (DHR) Long-Term Deferred Tax (2009 - 2010) Analysis & Trends
Danaher has reported Long-Term Deferred Tax for 2 years, with the latest figure at $175.0 million in Q4 2010.
- On a quarterly basis, Long-Term Deferred Tax fell 10.26% year-over-year to $175.0 million in Q4 2010; TTM through Dec 2010 was $175.0 million, a 10.26% decrease from a year earlier, with the FY2010 full-year figure at $175.0 million, down 10.26% from the prior year.
- Long-Term Deferred Tax was $175.0 million for Q4 2010 at Danaher, down from $195.0 million in the prior quarter.
- The five-year high for Long-Term Deferred Tax was $195.0 million in Q4 2009, with the low at $175.0 million in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |